ImunoTera

  • Biotech or pharma, therapeutic R&D

ImunoTera has developed a platform of active immunotherapies that teach the immune system to recognize and eliminate cancer cells, generating a long-term memory capable of avoiding recurrences and metastases. The first product, called TERAH-7, is a therapeutic vaccine aimed at treating cancer caused by HPV, such as cervical cancer.

Address

São Paulo
São Paulo
Brazil

Website

https://www.imunotera.com.br

Contact Exhibitor


Loading
View all Partnering Companies

white squarewhite

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS

Loading

Countdown